Press releases

These press releases are intended for business journalists and analysts/investors

GSK establishes Immunology Network to collaborate with academic research scientists

GSK has launched a new immunology research collaboration model – the Immunology Catalyst sabbatical program – designed to embed academic scientists in GSK laboratories with the goal to broaden scientific insight and drive major breakthroughs in applied immunology.

Australian Professor John Hamilton from the University of Melbourne was the first academic to join the program.

Read more - GSK establishes Immunology Network to collaborate with academic research scientists Read more

Boostrix availability

GSK prioritises whooping cough vaccine availability for those most at risk of the disease and confirms uninterrupted supply of Boostrix® to all Australian State, Territory and Federal Government vaccination programs where Boostrix is the vaccine of choice.

Read more - Boostrix availability Read more

Australian manufacturing innovation starts pilot with the hope it could reduce cost of vaccination in developing world

- Assistant Minister for Science Karen Andrews opens new vaccine facility in Boronia, Victoria
- GSK awarded $1 million Federal Government grant for advanced manufacturing project
- Three-year pilot to test commercialisation

Read more - Australian manufacturing innovation starts pilot with the hope it could reduce cost of vaccination in developing world Read more